China Regenerative Medicine International Limited (HKG:8158)
0.3600
-0.0150 (-4.00%)
Feb 13, 2026, 4:08 PM HKT
China Regenerative Medicine International Employees
China Regenerative Medicine International had 24 employees as of June 30, 2025.
Employees
24
Change
n/a
Growth
n/a
Revenue / Employee
2.43M HKD
Profits / Employee
52.83K HKD
Market Cap
109.53M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 24 | - | - | 24 | 0 |
| Dec 31, 2024 | 36 | -10 | -21.74% | 34 | 2 |
| Dec 31, 2023 | 46 | 23 | 100.00% | 42 | 4 |
| Dec 31, 2022 | 23 | 2 | 9.52% | 20 | 3 |
| Jun 30, 2022 | 24 | 0 | - | 24 | 0 |
| Dec 31, 2021 | 21 | -151 | -87.79% | 18 | 3 |
| Jun 30, 2021 | 24 | -345 | -93.50% | 24 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Oct 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Apr 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Uni-Bio Science Group | 504 |
| JW (Cayman) Therapeutics Co. | 292 |
| 3D Medicines | 183 |
| Transcenta Holding | 171 |
| Kintor Pharmaceutical | 136 |
| Beijing Biostar Pharmaceuticals | 131 |
| Sunho Biologics | 128 |
| Wuhan YZY Biopharma | 106 |